About Vesocclude
Vesocclude is a company based in Raleigh (United States) founded in 2005 was acquired by Symmetry Surgical in August 2015. Vesocclude has raised $1.52 million across 1 funding round from investors including Symmetry Surgical. Vesocclude operates in a competitive market with competitors including TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Saranas, among others.
- Headquarter Raleigh, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.52 M (USD)
in 1 rounds
-
Latest Funding Round
$1.52 M (USD), Seed
Oct 25, 2011
- Investors
-
Employee Count
Not available
-
Acquired by
Symmetry Surgical
(Aug 28, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Vesocclude
Vesocclude has successfully raised a total of $1.52M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.52 million completed in October 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vesocclude
Vesocclude has secured backing from 1 investor. Prominent investors backing the company include Symmetry Surgical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Surgical instruments, sterilization solutions and electrosurgical products
|
Locked | Locked | Locked |
Investor details for Vesocclude
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vesocclude
Investment portfolio details for Vesocclude
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vesocclude
Detailed financials for Vesocclude
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vesocclude Comparisons
Peer comparison for Vesocclude
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vesocclude
Vesocclude operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Saranas, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| Locked | Locked | Locked |
AV fistula maturation and patency are supported by VasQ device.
|
|
| Locked | Locked | Locked |
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
|
| Locked | Locked | Locked |
A device for vascular access management is developed.
|
|
| Locked | Locked | Locked |
A device is developed for detecting internal bleeding during catheterization.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
Detailed competitors of Vesocclude
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vesocclude
Complete news archive for Vesocclude
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vesocclude
Vesocclude was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Vesocclude is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Vesocclude is a funded company, having raised a total of $1.52M across 1 funding round to date.
Vesocclude is a medical device company specializing in advanced development of ligation products including superior manual ligating clips and loading devices for multiple medical specialties. Its ligation clips and appliers are used in surgical procedures to close tubal anatomic structures such as blood vessels or ducts. The portfolio consists of several sizes of titanium clips used to close the structures, which come loaded in a patented push and click cartridge system. Acquired by Symmetry Surgical in Aug 2015.
Vesocclude's top competitors include TISSIUM, Vivasure Medical and Cardival Medical.
Vesocclude has 1 investor. Key investors include Symmetry Surgical.